HUM-MOLGEN events: IBC's Drug Discovery for Inflammatory Diseases

HUM-MOLGEN -> Events -> Meetings and Conferences

IBC's Drug Discovery for Inflammatory Diseases

February 10, 2003

-, Sheraton Premiere at Tysons Corner, Vienna, VA
June 2-4, 2003

IBC’s Drug Discovery for Inflammatory Diseases offers an opportunity to receive a comprehensive update on the latest work in this field. You’ll learn about new targets in the signaling pathway upstream and downstream of the p38 MAP kinase, cytokine and chemokine receptor targets, academic and industry work in the new field of toll-like receptors and recent developments in the modulation of the GR and PPAR nuclear receptors. By attending, you’ll hear from thirty international experts in targeting the causes of chronic inflammation.

Organized by:

IBC Life Sciences

Invited Speakers:

"Clinical Update of Biologic Therapy in the Treatment of Rheumatoid Arthritis - Current and Future Trends"

- Edward Keystone, M.D., FRCP (C), Professor of Medicine, University of Toronto

Deadline for Abstracts:

Registration:

Online: www.LifeSciencesInfo.com/inflammation Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 Email: reg@ibcusa.com

E-mail:

reg@ibcusa.com

Posted by:

James G. Prudhomme